In vivo performance of decellularized tracheal grafts in the reconstruction of long length tracheal defects: Experimental study.

BACKGROUND: The repair of long-segment tracheal lesions remains an important challenge. Nowdays no predictable and dependable substitute has been found. Decellularized tracheal scaffolds have shown to be a promising graft for tracheal transplantation, since it is non-immunogenic. OBJECTIVE: Evaluate in vivo decellularized tracheal allografts performance to replace long tracheal segment. METHODS: Forty-five swines underwent surgery as follows: Fifteen trachea donors and 30 receptors of decellularized trachea allografts. The receptors were randomly divided in five groups (n = 6). In groups I and II, donor trachea segment was decellularized by 15 cycles with sodium deoxycholate and deoxyribonuclease, in group II, the allograft was reinforced with external surgical steel wire. Groups, III, IV, and V decellularization was reduced to seven cycles, supplemented with cryopreservation in group IV and with glutaraldehyde in group V. A 10 rings segment was excised from the receptor swine and the decellularized trachea graft was implanted to re-establish trachea continuity. RESULTS: Both decellularization cycles caused decreased stiffness. All trachea receptors underwent euthanasia before the third post-implant week due to severe dyspnea and trachea graft stenosis, necrosis, edema, inflammation, hemorrhage, and granulation tissue formation in anastomotic sites. Histologically all showed total loss of epithelium, separation of collagen fibers, and alterations in staining. CONCLUSIONS: Both decellularization techniques severely damaged the structure of the trachea and the extracellular matrix of the cartilage, resulting in a no functional graft, in spite of the use of surgical wire, cryopreservation or glutaraldehyde treatment. An important drawback was the formation of fibrotic stenosis in both anastomosis.

Experimental Tracheal Replacement: Angiogenesis and Null Apoptosis Promote Stenosis.

BACKGROUND: Tracheal replacement is a challenge for thoracic surgeons due to stenosis in the trachea-prosthesis anastomosis. We propose that stenosis occurs due to fibrosis as a result of an abnormal healing process, characterized by an increased expression of wound healing growth factors (vascular endothelial growth factor [VEGF], survivin, and CD31), which promote angiogenesis and decrease apoptosis. We analyzed the immunoreactivity of VEGF, survivin, CD31, and caspase-3 in the development of fibrotic stenosis in prosthetic tracheal replacement. METHODS: Fourteen dogs were operated on: group I (n=7) received a 6-ring cervical tracheal segment autograft, while in group II (n=7), a 6-ring segment of the cervical trachea was resected and tracheal continuity was restored with a Dacron prosthesis. The follow-up was 3 months. Immunoreactivity studies for VEGF, survivin, CD31, and caspase-3 were performed. A statistical analysis was done using the Wilcoxon signed rank test. RESULTS: Four animals in group I were euthanized on the 10th postoperative day due to autograft necrosis. Three animals completed the study without anastomotic stenosis. Moderate expression of VEGF (p=0.038), survivin (p=0.038), and CD31 (p=0.038) was found. All group II animals developed stenosis in the trachea-prosthesis anastomotic sites. Microscopy showed abundant collagen and neovascularization vessels. Statistically significant immunoreactive expression of VEGF (p=0.015), survivin (p=0.017), and CD31 (p=0.011) was observed. No expression of caspase-3 was found. CONCLUSION: We found a strong correlation between fibrosis in trachea-prosthesis anastomoses and excessive angiogenesis, moderate to intense VEGF, CD31, and survivin expression, and null apoptotic activity. These factors led to uncontrolled collagen production.

Fast cyclical-decellularized trachea as a natural 3D scaffold for organ engineering.

Commonly reported decellularization protocols for trachea may take up from several weeks to months in order to remove the cellular materials. Two years ago, we significantly reduced the time of decellularization trachea process using trypsin. Despite the positive outcome, the protocol was useful to produce 5 cm graft length, an unsuitable length graft for most patients with tracheal disorders. In this work we improved the decellularization procedure for longer sections up to 10 cm without considerable extension in the necessary time process (2 weeks). Herein, for the first time, we completely describe and characterize the process for pig tracheal bioactive scaffolds. Histological and molecular biology analysis demonstrated effective removal of cellular components and nuclear material, which was also confirmed by the Immunohistochemical (IHC) analysis of the major histocompatibility complexes (MHCs) and DNA stain by 4'-6-diamidino-2-phenylindole (DAPI). The images and data obtained from scanning electron microscopy (SEM) and thermal analysis showed conservation of the hierarchical structures of the tracheal extracellular matrix (ECM), the biomechanical tests showed that decellularization approach did not lead to a significant alteration on the mechanical properties. In this paper, we demonstrate that the proposed cyclical-decellularization protocol allowed us to obtain a non-immunological 10 cm natural tracheal scaffold according to the in vivo immunological assessment. Furthermore, the recellularization of the matrix was successfully achieved by demonstrating first-stage cellular differentiation from stem cells to chondrocytes expressed by the SOX9 transcription factor; this organ-engineered tracheal matrix has the potential to act as a suitable template for organ regeneration.

Surgical Skills Training with Cryopreserved Rat Stomachs.

The objective of this study is to present a high-fidelity bench model of cryopreserved stomachs that can be used while learning surgical skills. Thirty stomachs were harvested from Wistar rats at the end of non-abdominal research studies. The stomachs were washed with cold saline solution and filled with hyaluronic acid solution. The organs were then placed into cryovials and cryopreserved at -30 °C for 60 days. The stomachs were thawed to room temperature on the day of the surgical skills practice and two full-thickness incisions were made. Reporting on their experiences, 22 participants (73.33%) felt that the cryopreserved stomach was identical to in vivo rat stomachs, 24 (80.00%) reported that the stomach was easy to handle, and 27 (90%) reported the tissue was non-friable. Moreover, 29 participants (96.6%) finished the suturing without tears and 100% recommended it as a biomaterial for surgical training. The cryopreserved stomach is a practical, reproducible, low-cost, and high-fidelity bench model that allows surgical fellows to learn how to handle a stomach and improve their surgical abilities before performing surgery on patients or laboratory animals.

Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers.

BACKGROUND: Physicians do not routinely recommend smokers to undergo spirometry unless they are symptomatic. OBJECTIVE: To test the hypothesis that there are a significant number of asymptomatic smokers with chronic obstructive pulmonary disease (COPD), we estimated the prevalence of COPD in a group of asymptomatic smokers. METHODS: Two thousand nine hundred and sixty-one smokers with a cumulative consumption history of at least 10 pack-years, either smokers with symptoms or smokers without symptoms (WOS) were invited to perform a spirometry and complete a symptom questionnaire. RESULTS: Six hundred and thirty-seven (21.5%) smokers had no symptoms, whereas 2,324 (78.5%) had at least one symptom. The prevalence of COPD in subjects WOS was 1.5% when considering the whole group of smokers (45/2,961) and 7% when considering only the group WOS (45/637). From 329 smokers with COPD, 13.7% were WOS. Subjects WOS were younger, had better lung function and lower cumulative consumption of cigarettes, estimated as both cigarettes per day and pack-years. According to severity of airflow limitation, 69% vs 87% of subjects were classified as Global Initiative for Chronic Obstructive Lung Disease stages I-II in the WOS and smokers with symptoms groups, respectively (P<0.001). A multivariate analysis showed that forced expiratory volume in 1 second (mL) was the only predictive factor for COPD in asymptomatic smokers. CONCLUSION: Prevalence of COPD in asymptomatic smokers is 1.5%. This number of asymptomatic smokers may be excluded from the benefit of an "early" intervention, not just pharmacological but also from smoking cessation counseling. The higher forced expiratory volume in 1 second may contribute to prevent early diagnosis.

Bench surgical training with lyophilized esophageal segments

PURPOSE: To present lyophilized esophageal segments that can be used to learn surgical skills. METHODS: Four esophagus were harvested from four non-esophagus related research dogs at the moment of euthanasia. Each esophagus was trimmed in 3 cm long segments. They were lyophilized and stored during 30 days. The day programmed for surgical skills practice, they were rehydrated. RESULTS: Sixteen segments have been used. After rehydrating, all the segments kept their normal anatomic shape and structural integrity. One incision was made on every esophageal segment and sutured with running stitches of 3-0 polyglactin 910. There were no complications, such as tissue tears, nor esophageal hardening. CONCLUSIONS: The lyophilized esophagus is a high fidelity, practical, reproducible, portable, low-cost bench model. It allows general surgery apprentices to learn how to handle an esophagus, as well as to perfect their surgical and suture abilities before applying them on real patient's esophagus.

Bench surgical training with lyophilized esophageal segments.

PURPOSE: To present lyophilized esophageal segments that can be used to learn surgical skills. METHODS: Four esophagus were harvested from four non-esophagus related research dogs at the moment of euthanasia. Each esophagus was trimmed in 3 cm long segments. They were lyophilized and stored during 30 days. The day programmed for surgical skills practice, they were rehydrated. RESULTS: Sixteen segments have been used. After rehydrating, all the segments kept their normal anatomic shape and structural integrity. One incision was made on every esophageal segment and sutured with running stitches of 3-0 polyglactin 910. There were no complications, such as tissue tears, nor esophageal hardening. CONCLUSIONS: The lyophilized esophagus is a high fidelity, practical, reproducible, portable, low-cost bench model. It allows general surgery apprentices to learn how to handle an esophagus, as well as to perfect their surgical and suture abilities before applying them on real patient's esophagus.

Canine tracheal cartilage cryopreservation: freezing injury is not related to caspase-3 expression.

Currently, there are no surgical strategies to treat tracheal lesions longer than 7 cm. Such patients are not candidates for tracheal resection or end-to-end anastomosis and are thus left with only repeated palliative procedures to relieve their respiratory insufficiency. Experimental studies using cryopreserved trachea have produced contradictory results, limiting the clinical application of this technique. We evaluated caspase-3 expression and the histological integrity of canine tracheal cartilage cryopreserved using two different solutions, two temperatures, and varying lengths of storage time. Thirty canine tracheal segments of 5 rings were studied. Group 1: Control without cryopreservation. Groups 2 and 4: Cryopreserved in F12K media with 20% fetal bovine serum (FBS) at -70°C for 48 hours. Groups 3 and 5: Cryopreserved in 90% FBS at -70°C for 48 hours. Groups 4 and 5 were then stored for 15 days in liquid nitrogen. All of the segments were thawed, fixed in wax, and cut into rings. Three rings were selected for caspase-3 expression and histological evaluation. Staining of cartilage matrices was significantly modified in the tracheal segments of Group 5. The central region of the cartilage ring was more vulnerable to the effects of freezing than the edges. Under the same cryopreservation temperature and storage time, tracheal cartilage integrity is better preserved when F12K media is used. Caspase-3 expression is not related to cartilage injury from the cryopreservation process.

Cryopreserved tracheal segments: a new tool for bench surgical training in thoracic surgery.

PURPOSE: To present a new low-cost high fidelity bench model of cryopreserved trachea that can be used to learn surgical skills from medical students to cardiothoracic surgery fellows. METHODS: Ten tracheas were harvested from ten non-trachea related research dogs at the moment of euthanasia. Each trachea was trimmed in six or seven rings segments. They were cryopreserved and stored during 60 days. The day programmed for surgical skills practice, they were thawed to room temperature. RESULTS: Forty segments have been used. After defrosting, all the segments kept their normal anatomic shape and structural integrity. Two incisions were made on every tracheal segment and sutured with running or separate stitches with 5-0 polypropilene. There were no complications such as cartilage ruptures, neither tears on the mucosae, the cartilages nor the membranous posterior membrane. CONCLUSIONS: The cryopreserved trachea is a high fidelity, practical, reproducible, portable, low-cost bench model. It allows cardiothoracic fellows to learn how to handle a trachea, as well as to perfect their surgical and suture abilities before applying them on a real patient's trachea.

Cryopreserved tracheal segments: a new tool for bench surgical training in thoracic surgery / Segmentos criopreservados de traqueia: uma nova ferramenta para auxiliar o treinamento na cirurgia torácica

PURPOSE: To present a new low-cost high fidelity bench model of cryopreserved trachea that can be used to learn surgical skills from medical students to cardiothoracic surgery fellows. METHODS: Ten tracheas were harvested from ten non-trachea related research dogs at the moment of euthanasia. Each trachea was trimmed in six or seven rings segments. They were cryopreserved and stored during 60 days. The day programmed for surgical skills practice, they were thawed to room temperature. RESULTS: Forty segments have been used. After defrosting, all the segments kept their normal anatomic shape and structural integrity. Two incisions were made on every tracheal segment and sutured with running or separate stitches with 5-0 polypropilene. There were no complications such as cartilage ruptures, neither tears on the mucosae, the cartilages nor the membranous posterior membrane. CONCLUSIONS: The cryopreserved trachea is a high fidelity, practical, reproducible, portable, low-cost bench model. It allows cardiothoracic fellows to learn how to handle a trachea, as well as to perfect their surgical and suture abilities before applying them on a real patient's trachea.

OBJETIVO: Apresentar novo modelo de traquéia criopreservada de baixo custo e alta fidelidade que pode ser usado tanto por estudantes de medicina como por cirurgiões cardiotorácicos no aprendizado e desenvolvimento de suas habilidades cirúrgicas. MÉTODOS: Foram coletados amostras de dez traquéias de dez cães utilizados para pesquisa após a eutanásia. Cada segmento de traquéia foi dividida em seis ou sete anéis, criopreservadas e armazenadas durante 60 dias. No dia programado para a prática cirúrgica os segmentos foram descongelados a temperatura ambiente. RESULTADOS: Foram utilizados 40 segmentos no estudo. Após o descongelamento todos os segmentos mantiveram sua forma anatômica e sua integridade estrutural. Foram realizadas duas incisões em cada segmento traqueal que foram suturadas em padrão continuo ou com pontos separados utilizando sutura de polipropileno 5-0. Não houve nenhuma complicação como a ruptura da cartilagem, rasgos na mucosa, cartilagem ou na membrana membranosa posterior. CONCLUSÕES: O modelo de traquéia criopreservada é altamente fidedigno, prático, reproduzível, portátil e de baixo custo. Permite que os cirurgiões cardiotorácicos aprendam como manipular a traquéia, assim como aperfeiçoar suas habilidades cirúrgicas antes de sua aplicação em traquéias de pacientes reais.

[Experimental model of canine oleic acid-induced acute lung injury: establishment of a working model]. / Modelo experimental canino de daño pulmonar agudo producido con ácido oleico: estableciendo un modelo de trabajo.

INTRODUCTION: There are several experimental model of acute lung injury induced by oleic acid (OA); however, there are few studies that show how this injury develops. OBJECTIVE: This study seeks to detail the x-ray, hemodynamic, gasometrical, gravimetrical, macroscopic and microscopic alterations developed in an experimental model of canine OA-induced acute lung injury (ALI). MATERIAL AND METHODS: Twelve dogs were divided in 2 study groups: Group I (n=6): Control group without ALI. Group II (n=6); OA-induced ALI. All dogs were submitted to X-ray, hemodynamic and gasometric evaluation before ALI induction, and later every 15 minutes during 150 minutes. At the end of the study, the animals were euthanatized and were evaluated the changes gravimetric, macroscopic and microscopic in injured lungs. RESULTS: All the animals survived through the study. In group II, 100% of the animals developed x-ray (p < 0.003 Wilcoxon), hemodynamic, gasometrical and gravimetric (p < 0.5 ANOVA, Tukey), macroscopically and microscopically (p < 0.001 Wilcoxon) ALI. CONCLUSIONS: The OA-induced ALI is a model in which dogs develop X-ray, hemodynamic, gasometrical, gravimetrical, macroscopically and microscopically injuries of the exudative phase that lung with ALI injury presents.

Lyophilized glutaraldehyde-preserved bovine pericardium for experimental atrial septal defect closure.

A variety of patch materials has been used to close large atrial septal defects (ASD). Autologous pericardium and glutaraldehyde-preserved bovine pericardium are the most used. Lyophilized bovine pericardium has not been tested inside the cardiovascular system. The aim of this work was to study the behaviour and effectiveness of lyophilized glutaraldehyde-preserved bovine pericardium in ASD closure. Sixteen mongrel dogs were operated on. A 3 cm diameter atrial septal defect was created, and closed with: Group I (n=8): Lyophilized glutaraldehyde preserved bovine pericardium (LGPBP). Group II (n=8): Vascular Dacron patch. The animals were evaluated clinically, by echocardiography, macroscopically, and microscopically. Statistical analysis was done with analysis of variance (ANOVA) and Student's t-test. All the animals survived the surgical procedure and study time (6 months). Clinically all the animals displayed normal physical activity, with normal cardiac sounds. Echocardiography showed that both groups had a normal heart without intracardiac shunts, no thrombus formation, and no vegetations. Macroscopically all the animals showed good integration of the lyophilized bioprosthesis and Dacron patch. All group I animals presented a decrease of the area of the ASD in the left atrium (p<0.001 by ANOVA and Student's t-test). Microscopically, group I presented dense and well-organized collagenous tissue, areas of cartilaginous metaplasia and remnants of the lyophilized bioprosthesis (p<0.001 by ANOVA and Student's t-test). Group II showed encapsulated Dacron patch covered with collagenous tissue and cartilaginous metaplasia. In conclusion, the new lyophilized bioprosthesis is well integrated into the atrial septum, without complications and is effective for ASD closure.

Wound healing modulators in a tracheoplasty canine model.

Postsurgical tracheal stenosis results from fibrosis formation due to ischemia. There are healing modulators, hyaluronic acid (HA) and collagen polyvinylpyrrolidone (CPVP), which reduce collagen fibers formation. Thus we can hypothesize that the topical application of one of these modulators can diminish postsurgical tracheal scarring and stenosis. The aim of this work was to evaluate the macroscopic, microscopic, and biochemical changes of tracheal healing after the application of HA or CPVP in a canine tracheoplasty model. The study design was prospective experimental investigation in a canine model. Eighteen mongrel dogs underwent three cervical tracheal rings resection and end-to-end anastomosis. They were randomized into three groups according to treatment: group I (control group) (n = 6), topical application of saline solution on tracheal anastomosis; group II (n = 6), topical application of 15 microg HA on tracheal anastomosis; and group III (n = 6), topical application of 2.5 mg CPVP on tracheal anastomosis. They were evaluated clinical, radiological and tracheoscopically during 4 weeks. They were euthanized at the end of the study time. Macroscopic, microscopic, and biochemical changes of tracheal anastomosis healing were analyzed. Collagen formation was quantified by the Woessner method. All the animals survived the surgical procedure and study period. Macroscopic, radiologic, and endoscopic studies showed that animals in group I developed tracheal stenosis, inflammation, and firm fibrous tissue formation, and histological studies also showed severe inflammatory reaction and fibrosis formation. Groups II (HA) and III (CPVP) showed well-organized thin collagen fibers with minimal inflammatory response. Biochemical evaluation revealed a higher collagen concentration in group I animals (analysis of variance [ANOVA] p < .05 and Tukey p < .01). Thus, hyaluronic acid or collagen polyvinylpyrrolidone administered after tracheal anastomosis diminished the degree of stenosis and inflammatory reaction. Both modulators improved tracheal healing.

Trasplante experimental de tráquea cervical combinado con la aplicación de factor de crecimiento de fibroblastos / Experimental cervical trachea transplant combined with application of basic fibroblast growth factor

Antecedentes: El trasplante traqueal de longitudes mayores a 6 cm de longitud ha fallado por complicaciones isquémicas del injerto. Experimenta/mente se han utilizado factores de crecimiento y diferentes técnicas quirúrgicas, como la de trasplante traqueal dividido para favorecer la neoformación de vasos sanguíneos. Objetivo: Evaluar la viabilidad, cambios tráquea cervical, macroscópicos y microscópicos del trasplante de tráquea cervical en perros al utilizar la técnica quirúrgica de trasplante traqueal dividido, combinando la aplicación del factor básico de crecimiento para fibroblastos en los sitios de las anastomosis. Material y métodos: Se operaron 24 perros que fueron divididos en 4 grupos de estudio: Grupo I (n = 6): Trasplante de 9 anillos de tráquea cervical con la técnica convencional (TTCC); Grupo II (n = 6): TTCC e instilación tópica de factor básico de crecimiento de fibroblastos (bFGF) en los sitios de anastomosis; Grupo III (n = 6): Trasplante con la técnica de trasplante dividido (TTCD) y Grupo IV (n = 6): TTCD y aplicación de bFGF. Los animales recibieron triple inmunosupresión (azatioprina, metilprednisolona, ciclos-porína). Se planearon evaluaciones clínica, radiológica y traqueoscópica durante 4 semanas. Al final del estudio los injertos trasplantados se evaluaron macroscópica y microscópicamente. Resultados: Ningún animal concluyó su tiempo de estudio por disnea grave durante la primera semana del estudio. Macroscópicamente todos los injertos desarrollaron fístulas y necrosis. Microscópicamente mostraron necrosis, inflamación, vasculitis, hemorragia y destrucción del cartílago. Conclusión: En este estudio encontramos que el trasplante de tráquea cervical mayor a 6 cm, tiene malos resultados con la técnica quirúrgica convencional o dividida e inmunosupresión, así como con y sin la aplicación de bFGF en los sitios de anastomosis.

Background: Tracheal transplantation of lesions larger than 6 cm fails due to ischemic complications. Growth factors and different surgical techniques, including the divided tracheal graft technique, have been used experimentally to stimulate the neoformation of blood vessels. Objective: Assessment of the viability and macroscopic and microscopic changes of the cervical transplanted trachea in dogs, using the divided tracheal graft technique, combined with the application of basic fibroblast growth factor (bFGF) on the anastomotic site. Material and methods: Twenty four mongrel dogs were divided in 4 study groups: Group I (n = 6): Transplantation of 9 cervical tracheal rings with the conventional surgical technique (TCTC). Group II (n = 6): TCTC combined with topical instillation of bFGF at on the anastomotic line. Group III (n = 6): Transplantation of cervical trachea using the divided tracheal graft technique (TCTD), and Group IV (n = 6): TCTD with topical application of bFGF. The animals received triple immunotherapy (azathioprine, methylprednisolone, cyclosporine) and were to have clinical, radiological and endoscopical evaluation during 4 weeks. At the end of the study, macroscopic and microscopic evaluations of the transplanted grafts were done. Results: No animal completed the study time due to severe dyspnea during the first postoperative week. Macroscopically all grafts showed necrosis and fistulae formation. Microscopically we observed necrosis, inflammation, vasculitis, hemorrhage and destruction of cartilage in all the grafts. Conclusion: In this study, tracheal allotransplanta-tion longer than 6 cm with either surgical technique, with immunosuppression, with or without bFGF, is unsuccessful.

Cryopreserved tracheal grafts: a review of the literature.

Cryopreserved tracheal grafts have been used in several experimental models of long segment replacement. The clinical application of the procedure has been limited due to the fact that contradictory results have been reported. The purpose of this article is to present a review of the literature on tracheal cryopreservation. Despite the fact that most authors indicate that cryopreserved tracheal allografts retain viability and have a low immunological response, though they continue to function after transplantation with good epithelialization and patency, cryopreservation leads to significant damage to cartilage, the degree of which is based on the freezing-storage methods that affect the function and durability of a graft. The long-term storage of cartilage must therefore be investigated in more detail in basic research models of cartilage viability: the evaluation of chondrocyte apoptosis, and the use of different solutions for tracheal cryopreservation other than RPMI-1640, Dulbecco's modified Eagle's, Eurocollins, and TC-199. Furthermore, problems that involve improving the blood supply to the graft after extensive resection and immunosuppression must be resolved before tracheal cryopreservation can become a clinically established method for tracheal grafts.

Role of active and passive smoking on lung cancer etiology in Mexico City.

OBJECTIVE: [corrected] To estimate the association between passive and active smoking exposures and lung cancer in Mexico City and the corresponding attributable risks. MATERIAL AND METHODS: Data was analyzed from a multicenter population-based case-control study conducted in Mexico City. RESULTS: ORs for lung cancer in ever smokers were 6.2 (95% CI 3.9-10.2) for males and 2.8 (95% CI 1.7-4.4) for females. Passive smoking at home showed an overall OR of 1.8 (95% CI 1.3-2.6), similar in both genders. Attributable risk for active smoking for both genders combined, and for males and females separately, was estimated at 55, 76 and 27%, respectively. Attributable risk for passive smoking at home was 17% for females, 3.9% for males and 12% for the entire population. CONCLUSIONS: In Mexico City smoking is attributable to a smaller proportion of lung cancer cases than in developed countries. This is explained by a lower intensity of smoking in the Mexican population.

Role of active and passive smoking on lung cancer etiology in Mexico City

OBJETIVO: Estimar la asociación entre tabaquismo pasivo y activo y cáncer pulmonar (CP) en la Ciudad de México (CM), así como los riesgos atribuibles asociados.MATERIAL Y MÉTODOS: Se analiza un estudio multicéntrico de casos-controles con base poblacional, realizado en la CM. RESULTADOS: Las RM para CP en alguna vez fumadores fueron de 6.2 (IC 95% 3.9, 10.2) en hombres y 2.8 (IC 95% 1.7, 4.4) en mujeres. La exposición pasiva al tabaco mostró una RM en ambos sexos de 1.8 (IC 95% 1.3, 2.6), similar en ambos sexos. Los riesgos atribuibles asociados al tabaquismo activo para ambos sexos, hombres y mujeres fueron de 55, 76 y 27%, respectivamente. El riesgo atribuible para tabaquismo fue de 17% en mujeres, 3.9% en hombres y 12% en ambos sexos. CONCLUSIONES: En la CM el tabaquismo explica una fracción menor de casos de CP que el estimado en países desarrollados. Esto se debe a que en México la intensidad del tabaquismo es menor.

Uso del pericardio bovino tratado con glutaraldehído / Use of glutaraldehide-treated bovine pericardium

El uso de las prótesis mecánicas y biológicas surgió de la necesidad de reemplazar quirúrgicamente la falta o la falla de un órgano. Las bioprótesis están hechas a partir de tejido autólogo, homólogo y heterólogo. La bioprótesis de pericardio bovino tratada con glutaraldehído es la más estudiada y se utiliza principalmente como bioprótesis cardiaca. Debido a su fácil preparación y uso, este material se ha empleado para reparar defectos hemiarios de la pared abdominal, la pared torácica, de diafragma y para sustituir vasos y tráquea; sin embargo, causa reacción de rechazo y tipo cuerpo extraño, los que han sido estudiados ampliamente para evitarlos. Presentamos una revisión de la literatura sobre el uso y estudio de la bioprótesis de pericardio bovino tratado con glutaraldehído.

The use of biological and mechanical prostheses arose from the need to replace a failing organ or function. Bioprostheses can be manufactured from autologous, homologus or heterologus tissue; glutaraldehyde treated bovine pericardium bioprostheses have been used extensively to repair diaphragmatic, abdominal and chest wall defects and to replace heart valves, blood vessels and tracheal segments, but the implanted tissue can elicit rejection or foreign body reaction; these have been extensively studied in order to avoid them. We review the literature regarding glutaraldehyde treated bovine pericardium bioprostheses.

Trasplante de pulmón / Lung transplantation

Lung transplantation (LT) has evolved to become an Important alternative in the management of patients with end-stage pulmonary disease and chronic respiratory failure. The beginnings of this technique can be traced back to the experiments of Carrel and Guthrie over a hundred years ago. However, it was not until 1963 when the first clinical experience was performed by Hardy. Clinical success did not arrive until the 1980's thanks to the works of the Toronto Lung Transplant Group. Well established criteria have been described in order to consider a patient as a potential candidate to receive a lung. Several diseases are capable of causing terminal lung damage and in general they can be classified according to their origin as obstructive (COPD, emphysema), restrictive (fibrosis), chronic infectious (cystic fibrosis, bronquiectasis), and vascular (primary pulmonary hypertension). The most frecuent diagnosis is COPD. Clynically relevant modes of LT include the implant of one lung (single LT), or both lungs (bilateral sequential LT). Transplantation of the cardiopulmonary block is reserved for special situations and lobar transplantation is still considered experimental. Donor condition is essential to the success of LT. The potential donor patient frecuently suffers deterioration in lung function due to edema formation or infection and both complications restrict lung's using for transplantation. Lung preservation is also limited to a short period of time which rarely exceeds 6 hours in spite of specially-designed preservative solutions such as the low potassium dextran. Outcome after LT shows current one-year survival between 65-70% with reduction to 40-45% after five years. Mortality within the first year is usually related to primary graft failure and infection. Long-term survival depends on controlling infectious problems due to immunosupresion as well as the development of bronchilitis obliterans as a manifestation of chronic rejection. LT is a therapeutic modality reserved for selected patients with chronic respiratory failure due to end-stage lung disease.

El trasplante de pulmón se ha desarrollado como parte del manejo de pacientes con enfermedad pulmonar terminal que presentan insuficiencia respiratoria. Si bien los inicios de la técnica se encuentran en los experimentos de Carrel y Guthrie a principios del siglo XX, no fue sino hasta 1963 en que Hardy efectuó el primer trasplante pulmonar. Sin embargo, el éxito clínico no se tradujo en realidad sino hasta fines de los años ochenta gracias al esfuerzo del Grupo de Trasplante de la Universidad de Toronto. Existen criterios bien establecidos para considerar cuando un enfermo pulmonar terminal se encuentra en condiciones de ameritar un trasplante. Las patologías capaces de producir daño pulmonar terminal son muy variadas, pero en términos generales pueden dividirse en aquellas de origen obstructivo (EPOC, enfisema), las de tipo intersticial (fibrosis pulmonar), las de origen infeccioso crónico (fibrosis quística, bronquiectasias) y las de patología vascular (hipertensión pulmonar primaria). Con mucho el diagnóstico más frecuente es la EPOC. Es posible trasplantar un solo pulmón (trasplante unilateral) o bien los dos pulmones (trasplante bilateral secuencial). El trasplante del bloque cardiopulmonar se reserva para situaciones especiales y el trasplante lobar se considera aún experimental. Las condiciones del donador son especialmente importantes y constituyen muchas veces el principal obstáculo a vencer debido al deterioro pulmonar que sufren estos pacientes durante el manejo previo a la toma de decisión sobre la donación de los órganos. El deterioro pulmonar y la infección sobreagregada son los principales problemas que limitan la procuración de pulmones. La preservación pulmonar aún se encuentra limitada a un tiempo corto que rara vez excede las seis horas a pesar de utilizar soluciones especialmente diseñadas como lo es la de dextrán baja en potasio. Los resultados muestran una sobrevida a un año de entre 65-70% disminuyendo a 40-45% a los cinco años. Las causas de mortalidad dentro del primer año se relacionan con falla primaria del injerto, así como infecciones oportunistas. A largo plazo, además de infecciones oportunistas por la inmunosupresión se agrega el problema del desarrollo de bronquiolitis obliterante como manifestación de rechazo crónico. El trasplante pulmonar es una modalidad de manejo adecuada para pacientes seleccionados con falla respiratoria crónica secundaria a enfermedad terminal, sin embargo, se encuentra limitada por la disponibilidad de órganos para trasplantar.